...
首页> 外文期刊>Bioorganic and medicinal chemistry >Design, synthesis, and subtype selectivity of 3,6-disubstituted beta-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.
【24h】

Design, synthesis, and subtype selectivity of 3,6-disubstituted beta-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.

机译:3,6-二取代的β-咔啉在Bz / GABA(A)受体上的设计,合成和亚型选择性。 SAR和针对酒精滥用治疗剂的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 3,6-disubstituted beta-carbolines was synthesized and evaluated for their in vitro affinities at alpha(x)beta(3)gamma(2) GABA(A)/benzodiazepine receptor subtypes by radioligand binding assays in search of alpha(1) subtype selective ligands to treat alcohol abuse. Analogues of beta-carboline-3-carboxylate-t-butyl ester (betaCCt, 1) were synthesized via a CDI-mediated process and the related 6-substituted beta-carboline-3-carboxylates 6 including WYS8 (7) were synthesized via a Sonogashira or Stille coupling processes from 6-iodo-betaCCt (5). The bivalent ligands of betaCCt (32 and 33) were also designed and prepared via a palladium-catalyzed homocoupling process to expand the structure-activity relationships (SAR) to larger ligands. Based on the pharmacophore/receptor model, a preliminary SAR study on 34 analogues illustrated that large substituents at position-6 of the beta-carbolines were well tolerated. As expected, these groups are proposed to project into the extracellular domain (L(Di) region) of GABA(A)/Bz receptors (see 32 and 33). Moreover, substituents located at position-3 of the beta-carboline nucleus exhibited a conserved stereo interaction in lipophilic pocket L(1), while N(2) presumably underwent a hydrogen bonding interaction with H(1). Three novel beta-carboline ligands (betaCCt, 3PBC and WYS8), which preferentially bound to alpha1 BzR subtypes permitted a comparison of the pharmacological efficacies with a range of classical BzR antagonists (flumazenil, ZK93426) from several different structural groups and indicated these beta-carbolines were 'near GABA neutral antagonists'. Based on the SAR, the most potent (in vitro) alpha(1) selective ligand was the 6-substituted acetylenyl betaCCt (WYS8, 7). Earlier both betaCCt and 3PBC had been shown to reduce alcohol self-administration in alcohol preferring (P) and high alcohol drinking (HAD) rats but had little or no effect on sucrose self-administration.(1-3) Moreover, these two beta-carbolines were orally active, and in addition, were anxiolytic in P rats but were only weakly anxiolytic in rodents. These data prompted the synthesis of the beta-carbolines presented here.
机译:合成了一系列3,6-二取代的β-咔啉,并通过放射性配体结合试验寻找α(x)β(3)γ(2)GABA(A)/苯并二氮杂receptor受体亚型对其体外亲和力进行了评估。 1)亚型选择性配体可治疗酗酒。 β-咔啉-3-羧酸叔丁酯的类似物(betaCCt,1)通过CDI介导的方法合成,相关的6-取代的β-咔啉-3-羧酸6包括WYS8(7)的合成通过6-碘-βCCt的Sonogashira或Stille偶联过程(5)。还通过钯催化的均偶联工艺设计和制备了βCCt的二价配体(32和33),以将结构活性关系(SAR)扩展为更大的配体。基于药效基团/受体模型,对34个类似物的SAR初步研究表明,β-咔啉的6位大取代基具有良好的耐受性。如预期的那样,建议将这些基团投射到GABA(A)/ Bz受体的胞外域(L(Di)区)中(请参阅32和33)。此外,位于β-咔啉核的位置-3的取代基在亲脂性口袋L(1)中表现出保守的立体相互作用,而N(2)可能与H(1)发生氢键相互作用。三种优先与α1BzR亚型结合的新型β-咔啉配体(betaCCt,3PBC和WYS8)允许与几种不同结构组的一系列经典BzR拮抗剂(氟马西尼,ZK93426)的药理作用进行比较,并指出这些β-咔啉是“近GABA中性拮抗剂”。基于SAR,最有效的(体外)α(1)选择性配体是6-取代的乙炔基βCCt(WYS8,7)。较早的研究表明,betaCCt和3PBC均会降低喜欢酒精的(P)和高饮酒(HAD)大鼠的酒精自我给药,但对蔗糖的自我给药几乎没有影响。(1-3)此外,这两个beta咔啉具有口服活性,此外在P大鼠中具有抗焦虑作用,但在啮齿动物中仅具有弱抗焦虑作用。这些数据促使此处合成了β-咔啉。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号